Delayed 03:31:09 29/08/2026 HKT 5-day change 1st Jan Change
0.003000 EUR 0.00% Intraday chart for MagForce AG 0.00% +50.00%
3 months-25.00%
6 months-50.00%
1 month-33.33%
3 months-25.00%
6 months-50.00%
Current year+50.00%
1 week 0
Extreme 0.003
0
1 month 0
Extreme 0.003
0.01
Current year 0
Extreme 0.001
0.02
1 year 0
Extreme 0.001
0.02
3 years 0
Extreme 0.0002
0.02
5 years 0
Extreme 0.0002
0.02
10 years 0
Extreme 0.0002
0.02
Manager TitleAgeSince
Chief Executive Officer 86 01/09/2013
Director of Finance/CFO 55 01/10/2012
Director TitleAgeSince
Chairman 54 12/08/2021
Director/Board Member 45 -
Director/Board Member 54 -
Date Insider Type Main position Quantity % Market Cap.
16/12/20 Buy

Chief Executive Officer

250,000 0.9045%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-25.00%+50.00% 107K
-0.78%-1.42%+2.49%+22.78% 51.14B
-5.60%-0.38%+444.46%+546.81% 47.4B
-0.56%+0.78%+38.75%+18.06% 43.19B
-1.50%-2.12%+23.01%+81.36% 42.35B
-0.31%-1.75%+17.23%+52.37% 33.23B
-1.59%-3.10%+27.18%+129.88% 17.07B
-1.35%-2.32% - - 16.38B
-0.88%-0.63%+11.05%+29.54% 14.76B
-1.74%-1.45%+78.24%+46.37% 14.15B
Average -1.44%+0.63%+68.60%+108.58% 27.97B
Weighted average by Cap. -1.76%+1.12%+99.32%+138.10%

Financials

2020 2021
Net sales 1.5M 1.74M 1.41M 1.29M 2.42M 167M 2.43M 16.71M 6.52M 84.11M 6.55M 6.4M 279M 1.08M 1.25M 1.01M 922K 1.74M 119M 1.74M 11.98M 4.67M 60.31M 4.69M 4.59M 200M
Net income 14.75M 17.11M 13.83M 12.62M 23.78M 1.64B 23.85M 164M 64M 826M 64.25M 62.85M 2.74B -10.57M -12.27M -9.91M -9.05M -17.05M -1.17B -17.1M -118M -45.89M -592M -46.07M -45.07M -1.96B
Net Debt - -
Logo MagForce AG
Magforce AG is a Germany-based company engaged in the provision of nanotechnology solutions for health sector. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The Company's range of treatment products includes NanoTherm Therapie for treating tumors locally; NanoTherm, a fluid containing ferrous oxide molecules that penetrate deeply into the tumor tissues and reacting to the presence of a magnetic field; NanoActivator, which are iron oxide nanoparticles for tumors in all areas of the body, and NanoPlan, a software platform that facilitates therapy planning and adjusts proper temperatures for the treatment and and the necessary magnetic field strength. As of December 31, 2011, Nanostart AG held a 49.6%-stake in the Company.
Employees
33
Date Price Change Volume
29/08/26 0.003000 0.00% 0
27/08/26 €0.003000 0.00% 1,780
26/08/26 €0.003000 0.00% 3,400
25/08/26 €0.003000 0.00% 1,000
24/08/26 €0.003000 0.00% 0